{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:57:56Z","timestamp":1755223076933,"version":"3.43.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.trsl.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:25:58Z","timestamp":1752596758000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Platelet bound B cells and their role in SSc: Implications for disease subtypes and clinical outcomes"],"prefix":"10.1016","volume":"282","author":[{"given":"Rub\u00e9n","family":"Osuna-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Castellv\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Tandaipan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Codes-Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa \u00c0ngels","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Diaz-Torn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Cant\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Magallares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Guinart-Cuadra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Corominas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3909-6682","authenticated-orcid":false,"given":"Silvia","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2025.07.001_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncprheum0346","article-title":"Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis","volume":"2","author":"Sakkas","year":"2006","journal-title":"Nat Clin Pr Rheumatol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0002","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jbspin.2006.01.022","article-title":"Prognostic markers for systemic sclerosis","volume":"73","author":"Meyer","year":"2006","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.trsl.2025.07.001_bib0003","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2025.07.001_bib0004","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/art.24049","article-title":"Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4","volume":"58","author":"Fineschi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2025.07.001_bib0005","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2025.07.001_bib0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jcp.2004.019224","article-title":"Alterations of mononuclear inflammatory cells, CD4\/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis","volume":"58","author":"Hussein","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0007","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2025.07.001_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0009","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.gene.6364180","article-title":"Interleukin-10 genotypes are associated with systemic sclerosis and influence disease-associated autoimmune responses","volume":"6","author":"Hudson","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.trsl.2025.07.001_bib0010","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2025.07.001_bib0011","article-title":"The effects of interleukin-35 and interleukin-10 on pulmonary inflammation and fibrosis in a bleomycin-induced systemic sclerosis mouse model","author":"Huang","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0012","first-page":"S19","article-title":"Vascular involvement in systemic sclerosis (SSc)","volume":"22","author":"Kahaleh","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0013","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2012.00160","article-title":"The role of platelets in the pathogenesis of systemic sclerosis","volume":"3","author":"Ramirez","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0014","first-page":"105","article-title":"Vascular involvement in systemic sclerosis (scleroderma)","volume":"4","author":"Pattanaik","year":"2011","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.trsl.2025.07.001_bib0015","first-page":"183","article-title":"Platelet activation in patients with systemic scleroderma\u2013pattern and significance","volume":"45","author":"Agache","year":"2007","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.trsl.2025.07.001_bib0016","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10875-008-9252-x","article-title":"Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity","volume":"29","author":"Yoshizaki","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2473164","article-title":"Association of platelet binding to lymphocytes with B cell abnormalities and clinical manifestations in systemic Lupus Erythematosus","volume":"2019","author":"Zamora","year":"2019","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.trsl.2025.07.001_bib0019","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2025.07.001_bib0020","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0021","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"issue":"24","key":"10.1016\/j.trsl.2025.07.001_bib0022","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.3390\/cancers13246167","article-title":"Effector mechanisms of CD8+ HLA-DR+ T cells in breast cancer patients who respond to neoadjuvant chemotherapy","volume":"13","author":"Osuna-G\u00f3mez","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.trsl.2025.07.001_bib0023","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/imm.13596","article-title":"The immunoregulatory role of IL-35 in patients with interstitial lung disease","volume":"168","author":"Osuna-G\u00f3mez","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2025.07.001_bib0024","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1182\/blood-2012-05-432575","article-title":"Defective regulatory B-cell compartment in patients with immune thrombocytopenia","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2025.07.001_bib0025","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.1601708","article-title":"Binding of platelets to lymphocytes: a potential anti-inflammatory therapy in rheumatoid arthritis","volume":"198","author":"Zamora","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571321","article-title":"Flow cytometry-based protocols for the analysis of Human plasma cell differentiation","volume":"11","author":"Khoenkhoen","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.trsl.2025.07.001_bib0027","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/cancers14102529","article-title":"Influence of malignant pleural fluid from lung adenocarcinoma patients on neutrophil response","volume":"14","author":"Mulet","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trsl.2025.07.001_bib0028","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1538-7836.2006.01817.x","article-title":"Platelet\u2013lymphocyte conjugation differs between lymphocyte subpopulations","volume":"4","author":"Li","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2025.07.001_bib0029","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2025.07.001_bib0030","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1182\/blood-2018-99-117833","article-title":"Phenotype of platelets are altered and activated in circulation of patients with systemic sclerosis","volume":"132","author":"Yasuoka","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2025.07.001_bib0031","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/s44321-024-00093-3","article-title":"Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes","volume":"16","author":"Hawwari","year":"2024","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.trsl.2025.07.001_bib0032","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.ajpath.2012.02.009","article-title":"Platelet-derived growth factor-BB mediates cell migration through induction of activating transcription factor 4 and tenascin-C","volume":"180","author":"Malabanan","year":"2012","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.trsl.2025.07.001_bib0033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/svn-2022-001498","article-title":"MALAT1 promotes platelet activity and thrombus formation through PI3k\/Akt\/GSK-3\u00ce2 signalling pathway","volume":"8","author":"Sun","year":"2023","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0034","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1038\/jid.2015.336","article-title":"Platelet-activating factor induces epigenetic modifications in Human mast cells","volume":"135","author":"Damiani","year":"2015","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cmet.2020.12.006","article-title":"Platelets facilitate the wound-healing capability of mesenchymal stem cells by mitochondrial transfer and metabolic reprogramming","volume":"33","author":"Levoux","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2025.07.001_bib0036","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cmet.2023.12.020","article-title":"Targeting Erbin-mitochondria axis in platelets\/megakaryocytes promotes B cell-mediated antitumor immunity","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2025.07.001_bib0037","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.exphem.2007.05.021","article-title":"Human platelets can activate peripheral blood B cells and increase production of immunoglobulins","volume":"35","author":"Cognasse","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.trsl.2025.07.001_bib0038","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10753-013-9716-x","article-title":"Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis","volume":"37","author":"Soydinc","year":"2014","journal-title":"Inflammation"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524425000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524425000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:08:28Z","timestamp":1754910508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524425000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S1931524425000751"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2025.07.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"type":"print","value":"1931-5244"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet bound B cells and their role in SSc: Implications for disease subtypes and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}